Barclays

Pfizer Inc. (NYSE: PFE) reported forecast-beating second-quarter results Tuesday and raised its full-year guidance. The beat-and-raise quarter — and an update on its coronavirus vaccine program — sent the biopharma's shares higher by 3.94%. The Pfizer Analysts: BofA Securities...

Snap Inc (NYSE: SNAP) shares traded lower by 8% on Wednesday after the company reported a $326 million net loss in the second quarter, up from a $255 million loss a year ago. Snap reported a 9-cent EPS loss on the quarter, in-line with consensus analyst estimates. Revenue of $454 million exceeded...

Wall Street pros and traders are playing a game with novice Robinhood users and other retail investors, according to CNBC's Jim Cramer. Yet this stance isn't supported by a deep dive look into retail trading by Barclays. Cramer Says Wall Street Pros Prey On 'Stupid' People:...

Barclays PLC (NYSE: BCS) has seen a sharp decline in its first-quarter net profit while having to take a credit impairment charge of $2.62 billion reflecting the bank’s initial estimate regarding the impact of COVID-19. What Happened The London-headquartered bank’s net profit stands at...

Biogen Inc (NASDAQ: BIIB) shares shed close to 10% Wednesday following the revelation that the BLA filing for the company's Alzheimer's investigational drug aducanumab will be delayed. The Biogen Analysts Barclays analyst Carter Gould maintained an Overweight rating on Biogen...

Financial regulators in Britain are investigating Barclays PLC's (NYSE: BCS) CEO Jes Staley for his ties to the deceased sex offender Jeffrey Epstein.  What Happened The Financial Conduct Authority and the Prudential Regulation Authority are investigating links between...

Tesla Inc (NASDAQ: TSLA) has been running in insanity mode this week. Shares dropped more than 17% on Wednesday, the stock’s second worst day in history. The sell-off came just two days after the stock hit an all-time intra-day high of $961.86 and gained 19.9%, its single best day in more...

L Brands Inc (NYSE: LB) has notable upside potential and there are two paths to unlocking value, according to Barclays. The Analyst Adrienne Yih upgraded L Brands from Underweight to Overweight with a price target lifted from $15 to $30. The Thesis L Brands could move higher if one of two scenarios...

Industry data cross 5,000 projects that are ongoing or in the pipeline suggests First Solar, Inc. (NASDAQ: FSLR) is "in trouble," according to Barclays. The Analyst Moses Sutton downgraded First Solar from Overweight to Underweight with a price target lowered from $66 to $49. The Thesis...

Around the holidays Amazon.com Inc. (NASDAQ: AMZN) is probably best known for being one of Santa's biggest helpers, delivering presents to homes at a furious pace. But as the company rolls out several new Amazon Web Services products and new innovations in machine learning, and its Amazon...

JD.Com Inc (NASDAQ: JD) reported strong third-quarter results, beating the Street’s expectations for revenue, margin and user growth. More importantly, JD.Com achieved successful execution of its expansion strategy in lower-tier cities, which should provide traction for top-line growth,...

Diplomat Pharmacy Inc (NYSE: DPLO) cautioned investors on Tuesday that it has "substantial doubts" related to its ability to continue functioning as a business. Some analysts aren't ready to throw in the towel just yet — and see upside after Tuesday's all-time lows...

Barclays is out Neutral on U.S. specialty retail, apparel and e-commerce stocks on the basis of an an improving tariff backdrop that's offset by sector-wide inventory build, negative mall traffic and general oversupply. Analyst Adrienne Yih said she has a positive view of...